Resource Links

Status	Official Title	Lead Investigator	Last Updated
Finalised	A non-interventional, open observational non-inferiority study in two cluster-assigned cohorts of children aged 14 months into the safety of NeisVac-C® vaccines manufactured at two different production sites and given simultaneously with measles-mumps-rubella vaccine, assessed by web-based intensive monitoring	Dr Eugene van Puijenbroek	05/07/2017
Ongoing	Venlafaxine exposure in pregnancy, a multicenter ENTIS study	Miss Bernke te Winkel	10/02/2020
Ongoing	Pregnancy outcome after in utero exposure to baclofen: an ENTIS collaborative study	Dr Nathalie BERNARD	23/11/2016
Planned	Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines	Dr Caitlin Dodd	22/09/2020